Hair & Scalp

Baricitinib Shows Hair Regrowth in Phase 3 Study for AA
April 08, 2021

Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first Phase 3 study with top-line results in patients with the hair disorder.

AAD Announces Grant Program for Hair Disorders to Begin Accepting Applications Soon
April 02, 2021

The AAD announced it will begin accepting applications soon for its 2021 Hair Loss and Alopecia Initiative in Research (HAIR) Grant Program, which focuses on helping fund research for hair disorders, especially in diverse populations.

Quantifying is Key to Effective Hair Loss Treatment
March 09, 2021

Trichometric analysis helps evaluate whether treatment is working for patients experiencing hair loss and what adjustments need to be made to the regimen.